PRDM16-related signaling pathways are involved in the pathogenesis of obesity and diabetes, and intervening in PRDM16 expression or affecting the function of PRDM16 is likely to be an effective strategy to treat these diseases. The gene discussed is PRDM16; the disease is obesity due to melanocortin 4 receptor deficiency.